VRWorkout Launches a Future-of-Fitness Experience, Revolutionizing Workouts with Controller-Free Gameplay
DOVER, Delaware, March 22, 2023 /PRNewswire/ -- XRWorkout, an extended reality company company, announces the launch of the VRWorkout fitness experience in the Meta Quest store. Using first-of-its-kind controller-free gameplay, VRWorkout builds on Meta Quest hand-tracking to unlock true bodyweight exercises like pushups, crunches, planks and burpees. The result is a high-intensity...
Dignitana enters Hong Kong market with leading distributor Science International Corporation
LUND, Sweden, March 22, 2023 /PRNewswire/ -- Scalp cooling innovator Dignitana AB has signed Science International Corporation, a leading distributor for medical devices, to launch The DigniCap Scalp Cooling System in Hong Kong and Macao. Science International now becomes the exclusive provider of DigniCap in Hong Kong and Macau to minimize hair loss from chemotherapy. The company has already purchased two...
Zylox-Tonbridge Assisted Turkish Hospitals in Post-earthquake Recovery
HANGZHOU, China, March 22, 2023 /PRNewswire/ -- Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK, "the Company"), one of the leading players in the neuro- and peripheral-vascular interventional medical device market in China, announced its plans to provide free replacement services for products damaged in the recent earthquake that hit Turkey. The Company aims to meet the local patients' medical needs...
Jacobio announces clinical collaboration to evaluate CD73 monoclonal antibody JAB-BX102 in combination with KEYTRUDA® (pembrolizumab) for patients with cancer
BEIJING, SHANGHAI and BOSTON, March 22, 2023 /PRNewswire/ -- Jacobio Pharma (1167.HK) announced it has entered into a clinical collaboration with Merck & Co., Inc., Rahway, NJ, USA to evaluate the combination of Jacobio's CD73 monoclonal antibody JAB-BX102 in combination with Merck & Co., Inc., Rahway, NJ, USA's anti-PD-1 therapy, KEYTRUDA® (pembrolizumab). The clinical study...
3SBio announces 2022 annual results, with revenue rising 7.5% year on year and normalized net profit attributable to parents jumping 25.2%
HONG KONG, March 22, 2023 /PRNewswire/ -- Chinese leading biopharmaceutical company 3SBio (01530.HK) today announced its 2022 annual results. In 2022, 3SBio's core biopharmaceutical products posted robust growth, hair health business achieved blistering performance, and contract development and manufacturing organization (CDMO) business demonstrated big potential. New drugs started to embrace a commercialization wave, and license-out and license-in partnerships geared up....
APACMed Names EVERSANA Knowledge Partner to Shape Digital Health Reimbursement Framework Across Region
SINGAPORE, March 22, 2023 /PRNewswire/ -- Asia Pacific Medical Technology Association (APACMed), the region's leading organization for medical technology manufacturers, has named EVERSANA®, a pioneer of next-generation commercial services to the global life sciences industry and a market leader in helping digital health technology innovators navigate the complexity of bringing new therapies...
DEBIOPHARM ANNOUNCES LAUNCH OF THE PHASE 1/2 GaLuCi™ STUDY FOR ITS CA IX-TARGETED RADIOPHARMACEUTICAL PROGRAM
Debiopharm is developing personalized radiotherapy through a theranostic approach, combining diagnostic imaging (Debio 0328 a gallium-labelled imaging tool) and therapeutic components (Debio 0228, a lutetium-labelled radioligand), thus allowing the pre-identification and treatment of patients expressing CA IX. The GaLuCi™ trial is the first-in-human, multicenter, non-randomized phase 1/2 clinical trial assessing safety and tolerability, imaging characteristics and the efficacy of the...
See-Mode Technologies Secures Regulatory Approvals for its AI-powered Software that Automatically Analyses and Reports Breast & Thyroid Ultrasound Scans in Australia and New Zealand
MELBOURNE, Australia, March 22, 2023 /PRNewswire/ -- See-Mode Technologies, a leading provider of AI-powered medical imaging solutions, today announced that it has received regulatory approvals for its AI-powered breast and thyroid ultrasound solution in Australia and New Zealand. These approvals represent a significant milestone for the company, as it expands its presence...
Forests Reduce Health Risks, New Global Report Confirms
VIENNA, March 21, 2023 /PRNewswire/ -- The global scientific evidence of the multiple types of benefits that forests, trees and green spaces have on human health has now been assessed by an international and interdisciplinary team of scientists. The outcome is presented in a major report titled "Forests and Trees for Human...
RESTORE: The Foundation for Reconstructive Surgery 15th Anniversary Fundraiser Dinner Gala
Celebrating 15 years of FREE Reconstructive Surgeries Around the Globe The most beautiful and kind faces in Hollywood and dignitaries from around the world will come out to celebrate a good cause; the 15th Anniversary RESTORE Fundraiser Dinner Gala is presented by Avi Sivan Abraham Foundation (ASAF), a philanthropic organization based in Cameroon. This magnificent event is hosted...
